Skip to main content
. 2021 Mar 26;54(5):983–986. doi: 10.1016/j.jmii.2021.03.008

Table 1.

Characteristics and performance of six anti-SARS-CoV-2 antibody test kits.

Test kit
Sensitivity Specificity PPV NPV Sensitivity + specificity
Method Manufacturer Target protein Target antibody
RDT using gold conjugate SD Biosensora NCP IgM 78.9 98.3 97.7 83.6 177.2
IgG 94.5 96.6 96.3 95.0 191.2
IgM or IgG 99.1 95.0 94.7 99.1 194.0
FIA using europium particles SD Biosensor NCP IgM 74.5 93.3 91.1 79.9 167.8
IgG 97.3 94.1 93.9 97.4 191.4
IgM or IgG 99.1 87.4 87.9 99.0 186.5
Boditech Med NCP IgM 14.5 99.2 94.1 55.7 113.7
IgG 99.1 94.1 94.0 99.1 193.2
IgM or IgG 99.1 93.3 93.2 99.1 192.4
ELISA SD Biosensorb RBD & NCP Total antibody 96.3 100.0 100.0 96.7 196.3
PCL RBD & NCP Total antibody 98.2 100.0 100.0 98.3 198.2
EUROIMMUNc RBD IgG, OD ratio ≥0.8d 95.4 96.6 96.3 95.8 192.1
IgG, OD ratio ≥1.1 93.5 100.0 100.0 94.4 193.5

A total of 110 RT-PCR confirmed positive specimens and 119 negative control specimens were used, otherwise indicated.

Abbreviations: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; PPV, positive predictive value; NPV, negative predictive value; RDT, rapid diagnostic kit; FIA, fluorescence immunoassay; ELISA, enzyme-linked immunosorbent assay; NCP, nucleocapsid protein; RBD, receptor binding domain; COI, cut-off index; OD, optical density.

a

109 positive specimens were used.

b

108 positive specimens and 118 negative control specimens were used.

c

108 positive specimens and 117 negative control specimens were used.

d

Cut-off value for the borderline result.